Actively Recruiting

All Genders
NCT07460791

Alcon Hydrus Stent Implantation - Long Term Follow up After 8 Years

Led by Johannes Gutenberg University Mainz · Updated on 2026-03-10

200

Participants Needed

1

Research Sites

73 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to evaluate the long-term effectiveness and safety of the Hydrus implant combined with concomitant phacoemulsification for lowering intraocular pressure (IOP).Glaucoma patients often have high intraocular pressures (IOP) and need long-term IOP control to prevent loss of visual function and blindness. To date, data on the results of up to 5 years after Hydrus implantation have been published. However, to our knowledge, long-term data over a longer period of time are not yet available. The implementation of this study with a follow-up of the patients after ≥ 8 years (up to 14 years) represents the longest follow-up period to date with a cohort of up to 202 eyes in Mainz, Germany. It enables the collection of "real world data" ≥ 8 years after the Hydrus implantation and provides information about the current status of glaucoma and the effect of the Hydrus implant over this long period (including IOP status, IOP-lowering interventions that have taken place in the meantime, the status of the IOP-lowering medications used, ocular safety, quality of life etc.).

CONDITIONS

Official Title

Alcon Hydrus Stent Implantation - Long Term Follow up After 8 Years

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient participated in one of the following trials at the Mainz clinical trial site: HYDRUS I, HYDRUS II, HYDRUS IV, or the retrospective SPECTRUM data collection
  • Patient received either the Hydrus implant with phacoemulsification, the Hydrus implant alone, or phacoemulsification alone as a control
  • Patient has a minimum follow-up period after surgery of 8 years at the study visit
  • Willingness to participate in the study with signed and dated informed consent
  • Ability to provide consent
Not Eligible

You will not qualify if you...

  • Simultaneous participation in another interventional study or recent interventions with ongoing effects within 30 days

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Opthalmology

Mainz, Rhineland-Palatinate, Germany, 55131

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here